Rabeprazole sodium (Standard)

Overview

Rabeprazole (sodium) (Standard) is the analytical standard of Rabeprazole (sodium). This product is intended for research and analytical applications. Rabeprazole sodium (LY307640 sodium) is a second-generation proton pump inhibitor ( PPI ) that irreversibly inactivates gastric H + /K + -ATPase. Rabeprazole sodium induces apoptosis . Rabeprazole sodium acts as an uridine nucleoside ribohydrolase ( UNH ) inhibitor with an IC 50 of 0.3 μM. Rabeprazole sodium can be used for the research of gastric ulcerations and gastroesophageal reflux.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Proton Pump | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-B0656AR
• CAS No.: 117976-90-6
• Molecular Formula: C18H20N3NaO3S
• Molecular Weight: 381.42
• Purity: 95%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source